431
report
Distance as an Obstacle to Clinical Trial Access: Who Is Affected and Why It Matters
Access to clinical trials is valuable for patients as it provides the possibility to obtain novel t
reatments that are not yet commercially available.
+ Read More
panel
Common Sense from Uncommon Investors
With the emergence of rapidly rising interest rates and the resultant global recession fears, no
w is the time to remind investors about the cyclical nature of financial markets. Should managers batten down the hatches?
+ Read More
panel
Print is Not Dead
panel
Open Private Session (Invite only)
panel
Russia, Ukraine and its Neighborhood: Preparing to Win the Peace (Invite only)
While states make war, war totally remakes states. The Ukraine and Russia that finish the war wi
ll be radically changed from those before hostilities started.
+ Read More
panel
Open Private Session (Invite only)
panel
How Do Drugs Get Approved Faster Using RWE and AI?
Real-world evidence (RWE) and artificial intelligence (AI) have the potential to accelerate drug
development via multiple mechanisms, providing valuable insights into drug safety and efficacy in the real-world setting.
+ Read More
panel
The Path to Board Diversity: Moving the Needle from Progress to Maintenance (Invite only)
Board compositions are under increasing scrutiny worldwide when it comes to diverse representati
on.
+ Read More
panel
Philanthropy Leadership Collective | Roundtable Discussion with Private Medical Research Funders (Invite only)
Philanthropy is a powerful force within the health and medical research ecosystem, but funding b
iomedical research can have a steep learning curve. How do you learn where to begin? Who should you work with to implement your philanthropic goals?
+ Read More